Home › Acorda to buy developer of Parkinson's treatment
 

Keywords :   


Acorda to buy developer of Parkinson's treatment

2014-09-24 20:00:47| Biotech - Topix.net

Acorda Therapeutics Inc. plans to buy privately-held Civitas Therapeutics for $525 million in cash as the drugmaker seeks to expand into treatments for Parkinson's disease. Acorda, based in Ardsley, New York, makes drugs for patients with multiple sclerosis, spasticity and those who are experiencing pain after a shingles infection.

Tags: buy treatment developer acorda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
14.05The LOccitane Group Appoints Evelyne LY-Wainer Managing Director Global Travel Retail
14.05Recovery resources available for Texas livestock producers
14.05About-Face and AF94 Appoint Francesca Raminella as New CEO
14.05An unraveled genetic mystery in Angus
14.05Is HPAI a risk to beef cattle?
14.05Fresh Partners with Juno Shen on Limited-Edition Kombucha Facial Treatment Essence
More »